PHARMACIE LADURON: what changed
PHARMACIE LADURON
Largest movements
- Current investments +€230,000
new in 2025: €230,000
- Tangible fixed assets -€32,127
down €32,127 (-66.9%), from €48,009 to €15,882
of which Plant, machinery and equipment: -€35,296
- Cash -€6,794
down €6,794 (-14.1%), from €48,178 to €41,384
mainly Current investments (-€230,000) and Contributions, distributions and other (-€30,000)
- Stocks and contracts -€4,526
down €4,526 (-20.2%), from €22,431 to €17,905
- Receivables within one year -€3,494
down €3,494 (-16.4%), from €21,343 to €17,849
of which Other amounts receivable: -€3,130
- Reserves +€169,000
up €169,000 (+938%), from €18,016 to €187,016
- Other debts +€30,000
new in 2025: €30,000
- Profit (loss) carried forward -€29,516
down €29,516 (-31.6%), from €93,339 to €63,823
- Tax, wage and social debts +€13,335
up €13,335 (+584%), from €2,282 to €15,618
- Gross operating margin +€216,298
up €216,298 (+556%), from €38,869 to €255,167
- Taxes +€71,949
up €71,949 (+858%), from €8,387 to €80,336
- Depreciation -€5,164
down €5,164 (-47.1%), from €10,959 to €5,795
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €142,507 | €325,500 | +€182,994 | +128% |
| Fixed assets | 21/28 | €48,009 | €15,882 | -€32,127 | -66.9% |
| Tangible fixed assets | 22/27 | €48,009 | €15,882 | -€32,127 | -66.9% |
| Land and buildings | 22 | €7,734 | - | -€7,734 | |
| Plant, machinery and equipment | 23 | €35,296 | - | -€35,296 | |
| Furniture and vehicles | 24 | €4,979 | €15,882 | +€10,904 | +219% |
| Current assets | 29/58 | €94,497 | €309,618 | +€215,120 | +228% |
| Stocks and contracts in progress | 3 | €22,431 | €17,905 | -€4,526 | -20.2% |
| Stocks | 30/36 | €22,431 | €17,905 | -€4,526 | -20.2% |
| Amounts receivable within one year | 40/41 | €21,343 | €17,849 | -€3,494 | -16.4% |
| Trade receivables | 40 | €18,145 | €17,782 | -€363 | -2.0% |
| Other amounts receivable | 41 | €3,198 | €68 | -€3,130 | -97.9% |
| Current investments | 50/53 | - | €230,000 | +€230,000 | |
| Cash at bank and in hand | 54/58 | €48,178 | €41,384 | -€6,794 | -14.1% |
| Deferred charges and accrued income | 490/1 | €2,546 | €2,480 | -€66 | -2.6% |
| Total equity and liabilities | 10/49 | €142,507 | €325,500 | +€182,994 | +128% |
| Equity | 10/15 | €130,105 | €269,589 | +€139,484 | +107% |
| Contributions | 10/11 | €18,750 | €18,750 | = | 0.0% |
| Reserves | 13 | €18,016 | €187,016 | +€169,000 | +938% |
| Distributable reserves | 133 | €18,016 | €187,016 | +€169,000 | +938% |
| Profit (loss) carried forward | 14 | €93,339 | €63,823 | -€29,516 | -31.6% |
| Amounts payable | 17/49 | €12,402 | €55,911 | +€43,510 | +351% |
| Amounts payable within one year | 42/48 | €12,402 | €55,296 | +€42,894 | +346% |
| Trade debts | 44 | €10,119 | €9,678 | -€441 | -4.4% |
| Suppliers | 440/4 | €10,119 | €9,678 | -€441 | -4.4% |
| Taxes, remuneration and social security | 45 | €2,282 | €15,618 | +€13,335 | +584% |
| Taxes | 450/3 | €2,282 | €15,618 | +€13,335 | +584% |
| Other amounts payable | 47/48 | - | €30,000 | +€30,000 | |
| Accrued charges and deferred income | 492/3 | - | €615 | +€615 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,959 | €5,795 | -€5,164 | -47.1% |
| Other operating charges | 640/8 | €3,711 | €1,718 | -€1,993 | -53.7% |
| Gross operating margin | 9900 | €38,869 | €255,167 | +€216,298 | +556% |
| Operating profit (loss) | 9901 | €24,199 | €247,654 | +€223,455 | +923% |
| Financial income | 75/76B | €2 | €2,393 | +€2,391 | +99,613% |
| Recurring financial income | 75 | €2 | €2,393 | +€2,391 | +99,613% |
| Financial charges | 65/66B | €135 | €228 | +€92 | +68.3% |
| Recurring financial charges | 65 | €135 | €228 | +€92 | +68.3% |
| Profit (loss) for the period before taxes | 9903 | €24,066 | €249,819 | +€225,753 | +938% |
| Income taxes | 67/77 | €8,387 | €80,336 | +€71,949 | +858% |
| Profit (loss) for the period | 9904 | €15,680 | €169,484 | +€153,804 | +981% |
| Profit (loss) for the period to be appropriated | 9905 | €15,680 | €169,484 | +€153,804 | +981% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.